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ylene.* The annuloplasty was performed with the Wooler
technique. During the postoperative course, tricuspid valve
residual stenosis was treated by balloon valvuloplasty.
Fourteen months later, the patient was readmitted with severe
heart failure (New York Heart Association [NYHA] class IV).
Transthoracic echocardiography (TTE) showed severe tricus-
pid regurgitation with very important dilatation of the right
atrium and ventricle and a lower right ventricular shortening
fraction (18%). A mitral homograft was selected for tricuspid
replacement. The homograft was obtained from a recipient’s
heart explanted during a transplant operation. The harvest
preparation and cryopreservation were performed according
to previously described techniques.3 Anatomic features of the
homograft were as follows: diameter (Carpentier obturator),
30 mm; distance between the papillary muscle apex and the
valve anulus, 35 mm. The papillary muscle classification
according to the Acar technique was type II.
Surgical technique. After total valvular and subvalvular tis-
sue resection (not including papillary muscles), mitral homo-
grafts were inserted, with several obligatory differences deter-
mined by using the Acar technique.3 The feasibility of the
orientation as to position of the anterior (septal) leaflet at the
level of the septum was not possible because the large and
long anteromedial papillary muscle was protruding into the
infundibular channel, producing right ventricular outflow
tract obstruction. Then the posterior homograft leaflet was
orientated to the septal position. Circumferential sutures were
performed between the homograft and native tricuspid anulus.
The posterior papillary muscle was inserted into a trench fash-
ioned in the muscular interventricular septum. The anterome-
dial papillary muscle was very long, and a transparietal inser-
tion on the epicardial surface of the apex was necessary. A
Tricuspid valve replacement in children is a very uncom-
mon procedure. Valvular replacement is a hard decision
because of its hazardous implications. Large percentages of
side effects complicate the use of mechanical prostheses and
heterografts. Recent publications about the use of atrioven-
tricular valve homografts indicated a promising future and
showed the feasibility of this technique in a clinical situa-
tion.1-3 We report 2 cases of total replacement of the tricuspid
valve with a cryopreserved mitral homograft in young chil-
dren with previous cardiac operations.
Clinical summaries. 
PATIENT 1. An 11-month-old boy was referred in November
1994 for active infective endocarditis caused by
Staphylococcus aureus. Echocardiography showed several
large spots of vegetation in all the tricuspid leaflets, including
the subvalvular region, with severe tricuspid regurgitation.
The patient was in hemodynamically unstable condition, and
the infection was not controlled by medical therapy.
Reconstructive surgery was undertaken by resection of the
vegetation, leaflet tissue, and chordal involvement. Repair
was performed with autologous pericardial patches and recon-
struction of the subvalvular apparatus with polytetrafluoroeth-
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heterograft valves were associated with a lower operative
mortality but with a very rapid degeneration and calcification.
Use of a mitral homograft is an appealing alternative.
In our short experience we advise initial attachment of the
leaflet tissue to the anulus to allow determination of the
appropriate site of implantation of the papillary muscle on the
ventricular wall.4
Because of the anatomy of the homograft and the right ven-
tricle in patient 1, we placed the homograft according to the
Pomar technique.2 Nevertheless, we prefer not to orientate
the homograft in this way. The use of an annuloplasty ring
with mitral devices offers the advantage of remodeling the
shape like that of a mitral orifice. In patient 1, with no rotat-
ing homograft, an annuloplasty was not feasible because the
septal leaflet position was anterior, and it would be severely
affected by the ring.
The transmural fixation of the papillary muscles probably
solved the late problems (sudden rupture) of the papillary
muscle attachment.5 The main problem of replacement of
atrioventricular valves with homografts is their durability,
which probably depends on the continued tissue viability.
With this method of valve replacement, part of the subvalvu-
lar apparatus is preserved so that its important role in ven-
tricular function is retained. At present, the major indication
for homograft replacement of the atrioventricular valves is to
replace a destroyed tricuspid valve (mainly in children)
where previous conservative techniques had failed. The atrio-
ventricular valve homograft is actually the most resistant
valve to severe infection, and in the tricuspid position resid-
ual dysfunction is well tolerated.
Conclusions. Homotransplantation of unstented cryopre-
served mitral homograft in tricuspid position seems to be a
method with high biologic and clinical potentials, with better
blood flow characteristics, less thrombogenicity, and more
resistance to infection than mechanical or biologic prosthesis.
Although a larger and longer experience is mandatory, the use
of mitral homograft in tricuspid position may represent a
valuable alternative, especially in children.
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pericardial patch was used for covering the muscle. An annu-
loplasty ring was not used. Intraoperative TTE showed satis-
factory functional status with moderate prolapse of the homo-
graft leaflets. The postoperative outcome was uneventful, and
complete recovery of the functional status was accomplished.
Ten days later, the patient was discharged. After 4 years’ fol-
low-up, the patient remains asymptomatic, with sinus rhythm
and NYHA class I. TTE showed normal function of the
homograft without regurgitation or gradient.
PATIENT 2. A 12-year-old girl had had a Danielson repair
for severe Ebstein malformation at 4 years of age and a tri-
cuspid valvuloplasty for severe tricuspid regurgitation 6
years later. She was readmitted in March 1997 with severe
heart failure. Because of severe massive tricuspid regurgita-
tion confirmed by TTE, we proposed tricuspid valvular
replacement with cryopreserved mitral homograft. A mitral
homograft was harvested from a cadaveric donor not suit-
able for heart transplantation. Anatomic features of the
homograft were as follows: diameter (Carpentier obturator),
30 mm; distance between the papillary muscle apex and the
valve anulus, 33 mm; papillary muscle classification
according to Acar,3 type II.
Surgical technique. The Danielson repair of the Ebstein
anomaly was taken down, and remaining tricuspid tissue was
resected. The atrialized right ventricular pouch was longitu-
dinally plicated according to the Carpentier technique. The
repaired tricuspid anulus was 28 mm in diameter. The coro-
nary sinus was opened, and its internal surface was used like
the tricuspid septal anulus to avoid the conduction tissue. The
cryopreserved mitral homograft was inserted in the tricuspid
position according to previously published techniques, and it
was oriented so that the position of the anterior (septal) leaflet
was at the level of the septum.
Papillary muscles were inserted into a trench fashioned in
the interventricular septum and side to side on the anterior
native papillary muscle. A modified Duran (mitral device)
prosthetic ring was inserted. TTE showed very good func-
tional results. The outcome was successful, and the patient
was discharged 7 days later without fluid retention and with
only diuretic medication. Three years later, she was in NYHA
class I, without symptoms and with normal clinical and
echocardiographic function of mitral homograft. The anulus
measurement on high-resolution x-ray film was 27 mm.
Discussion. The surgical treatment of tricuspid valve endo-
carditis is controversial. In our experience with the excision-
only treatment, 4 of 5 children continue to have severe right
ventricular failure and a very handicapped life. The other
patient underwent successful heart transplantation. Valve
repair is an excellent technique when it is possible; however,
in the presence of extensive lesions, valve repair should not
be performed. Tricuspid valve replacement remains an
uncommon surgical procedure. The use of mechanical pros-
theses in the tricuspid position is associated with a high mor-
tality and morbidity (eg, high incidence of thrombotic com-
plications and valve dysfunction from tissue ingrowth).4 The
